Lesson plan
Bisorcic
Bisorcic ( ), also known as N 2 ,N 5 -diacetyl- L -ornithine, is a drug described as a hepatoprotective agent and "psychostimulant" which has been used in France in the treatment of asthenia. It is the N 2 ,N 5 -diacetylated derivative of the amino acid L -ornithine. Bisorcic was first described in the literature in 1973 in a German patent. The was designated around 1975. The drug was marketed in France by Astyl-Gallier in 1987. It was provided in the form of 200 mg oral capsules and four capsules were taken daily. L -Ornithine, as the combination drug L -ornithine L -aspartate (LOLA), has been used in the treatment of hepatic encephalopathy and cirrhosis and is likewise described as hepatoprotective. It is thought to work by participating in the urea cycle and lowering ammonia levels.
Article summary
Bisorcic ( ), also known as N 2 ,N 5 -diacetyl- L -ornithine, is a drug described as a hepatoprotective agent and "psychostimulant" which has been used in France in the treatment of asthenia. It is the N 2 ,N 5 -diacetylated derivative of the amino acid L -ornithine. Bisorcic was first described in the literature in 1973 in a German patent. The was designated around 1975. The drug was marketed in France by Astyl-Gallier in 1987. It was provided in the form of 200 mg oral capsules and four capsules were taken daily. L -Ornithine, as the combination drug L -ornithine L -aspartate (LOLA), has been used in the treatment of hepatic encephalopathy and cirrhosis and is likewise described as hepatoprotective. It is thought to work by participating in the urea cycle and lowering ammonia levels.
Key claims
No claims recorded.
Discussion questions
- Summarise the article in your own words. Which single claim would you verify first, and why?
- Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
- If two sources disagreed about one of these facts, what would you need in order to trust one over the other?
Bibliography
No sources recorded.
Key claims and bibliography are generated from the same tracked claims and sources as the article page.